TY - JOUR
T1 - Alveolar soft-part sarcoma in the sacrum
T2 - A case report and review of the literature
AU - Zadnik, Patricia L.
AU - Yurter, Alp
AU - Deleon, Rosa
AU - Molina, Camilo A.
AU - Groves, Mari L.
AU - McCarthy, Edward
AU - Sciubba, Daniel M.
N1 - Funding Information:
Acknowledgements This work was supported with funding from the AOSpine Foundation for the Knowledge Forum Primary Tumor Retrospective Study.
PY - 2014/1
Y1 - 2014/1
N2 - Alveolar soft part sarcoma (ASPS) is a rare disease of the soft tissue. Although the disease is rare, it is refractory to chemotherapy and radiation. En bloc surgical resection offers the best chance of cure. In this article we report the case of a 28-year-old woman who presented with buttock and leg pain, bowel, bladder and gait impairment and a large mass in the sacrum. Following surgical excision, the lesion was proven to be ASPS. On pathology, the mass was TFE3 (transcription factor E3) positive, indicating the presence of the ASPL-TFE3 (novel gene-transcription factor) translocation. Following surgery, the patient had improvement in her pain and ambulation; however, she refused adjuvant therapy to pursue hospice care and succumbed to her disease 2 years after surgery. On a review of the literature, it was found that ASPS of the bone constitutes a rare and formidable subset of this disease. Further, metastases related to ASPS are common in the lungs, liver, brain, and lymph nodes. The degree of dissemination is a predictor of outcome, with 5-year survival of 81-88 % in patients with local disease and only 20-46 % in patients with metastatic disease at the time of presentation. Brain metastases at the time of presentation portend the worst prognosis.
AB - Alveolar soft part sarcoma (ASPS) is a rare disease of the soft tissue. Although the disease is rare, it is refractory to chemotherapy and radiation. En bloc surgical resection offers the best chance of cure. In this article we report the case of a 28-year-old woman who presented with buttock and leg pain, bowel, bladder and gait impairment and a large mass in the sacrum. Following surgical excision, the lesion was proven to be ASPS. On pathology, the mass was TFE3 (transcription factor E3) positive, indicating the presence of the ASPL-TFE3 (novel gene-transcription factor) translocation. Following surgery, the patient had improvement in her pain and ambulation; however, she refused adjuvant therapy to pursue hospice care and succumbed to her disease 2 years after surgery. On a review of the literature, it was found that ASPS of the bone constitutes a rare and formidable subset of this disease. Further, metastases related to ASPS are common in the lungs, liver, brain, and lymph nodes. The degree of dissemination is a predictor of outcome, with 5-year survival of 81-88 % in patients with local disease and only 20-46 % in patients with metastatic disease at the time of presentation. Brain metastases at the time of presentation portend the worst prognosis.
KW - Alveolar soft part sarcoma
KW - Bone
KW - Cancer
KW - Sacrum
KW - Surgery
UR - https://www.scopus.com/pages/publications/84890959704
U2 - 10.1007/s00256-013-1737-x
DO - 10.1007/s00256-013-1737-x
M3 - Article
C2 - 24092236
AN - SCOPUS:84890959704
SN - 0364-2348
VL - 43
SP - 115
EP - 120
JO - Skeletal Radiology
JF - Skeletal Radiology
IS - 1
ER -